Heather M. Shaw

Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma

Karla A. Lee, Andrew Maltez Thomas, Laura A. Bolte et al. · Nature Medicine · 2022 · 429 citations · Full text

Life Sciences, Immunology, Microbiology +17

Phase I Dose Escalation Study of the Anti–Insulin-Like Growth Factor-I Receptor Monoclonal Antibody CP-751,871 in Patients with Refractory Solid Tumors

Paul Haluska, Heather M. Shaw, Gretchen N. Batzel et al. · Clinical Cancer Research · 2007 · 268 citations

Pharmacy, Oncology, Pharmacology +15

Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma

Johannes R. Björk, Laura A. Bolte, Andrew Maltez Thomas et al. · Nature Medicine · 2024 · 124 citations · Full text

Life Sciences, Microbiology, Oncology +17

The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study

L. Rhoda Molife, Peter C.C. Fong, Luisa Paccagnella et al. · British Journal of Cancer · 2010 · 85 citations · Full text

Medicine, Oncology, Pharmacology +17

Ipilimumab and Bevacizumab in Glioblastoma

T. Carter, Heather M. Shaw, Denise Cohn-Brown et al. · Clinical Oncology · 2016 · 82 citations · Full text

Medicine, Oncology, Pharmacotherapy +17